Top Markets
#1 Cortex Cortex +32.55%
#2 龙虾 (Lobster) 龙虾 (Lobster) +16.86%
#3 Akedo Akedo +12.21%
#4 wojak wojak +11.93%
#5 MarsCoin MarsCoin +11.23%
#6 Pons Pons +10.45%
#7 EXOD EXOD +9.04%
#8 The Black Bull The Black Bull +7.87%
#9 Seeker Seeker +7.61%
#10 Official Trump Official Trump +6.67%
Coin of the day
Cortex Cortex
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Dian Diagnostics Group Co.,Ltd. Dian Diagnostics Group Co.,Ltd.

Dian Diagnostics Group Co.,Ltd.

300244
Rang in Aktien #7118
Dian Diagnostics Group Co.,Ltd. operates as a leading independent provider of... Dian Diagnostics Group Co.,Ltd. operates as a leading independent provider of medical diagnostic services within China. The company delivers comprehensive diagnostic solutions to a broad spectrum of healthcare organizations, including general and specialized hospitals, community health centers, township clinics, physical examination facilities, and disease prevention and control agencies. Supporting its extensive operations, Dian Diagnostics manages a global network of 40 advanced chain laboratories. Beyond its core diagnostic offerings, the company is also deeply involved in the research, development, and manufacturing of in vitro diagnostic reagents, along with associated equipment and consumables. Furthermore, it plays a crucial role in the medical supply chain, facilitating the provision of various products such as medical equipment, pharmaceuticals, clinical samples, biological products, finished blood products, live animals, chemical compounds, and diagnostic reagents. Dian Diagnostics also specializes in comprehensive cold chain logistics, which includes transportation, warehousing, product sales, and technical support services for temperature-sensitive medical goods. Founded in 2001, the company is headquartered in Hangzhou, China. It adopted its current name, Dian Diagnostics Group Co.,Ltd., in November 2017, having previously operated as Zhejiang DIAN Diagnostics Co., Ltd.
Aktienkurs
$2.75
Marktkapitalisierung
$1.72B
Veränderung (1 Tag)
0.69%
Veränderung (1 Jahr)
12.26%
Land
CN
Handel Dian Diagnostics Group Co.,Ltd. (300244)

Kategorie

Healthcare
Gewinn für Dian Diagnostics Group Co.,Ltd. (300244)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Dian Diagnostics Group Co.,Ltd. betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Dian Diagnostics Group Co.,Ltd. von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
$7.61B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
$4.76B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
- -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
$-252.70M -
US
Agilent Technologies, Inc. Agilent Technologies, Inc.
Agilent Technologies, Inc.
A.US
$1.58B -
US